Mersana Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.

CEO

Martin H. Huber

CEOMartin H. Huber

Employees

102

Employees102

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2001

Founded2001

Employees

102

Employees102

MRSN Key Statistics

Market cap

42.96M

Market cap42.96M

Price-Earnings ratio

-0.57

Price-Earnings ratio-0.57

Dividend yield

—

Dividend yield—

Average volume

4.50M

Average volume4.50M

High today

$0.3965

High today$0.3965

Low today

$0.341

Low today$0.341

Open price

$0.381

Open price$0.381

Volume

4.53M

Volume4.53M

52 Week high

$2.83

52 Week high$2.83

52 Week low

$0.2589

52 Week low$0.2589

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own MRSN. This list is generated using Robinhood data, and it’s not a recommendation.